Comparative Risk Predictions of Second Cancers After Carbon-Ion Therapy Versus Proton Therapy.

Int J Radiat Oncol Biol Phys

Department of Physics and Astronomy, Louisiana State University and Agricultural and Mechanical College, Baton Rouge, Louisiana; Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana.

Published: May 2016

Purpose: This work proposes a theoretical framework that enables comparative risk predictions for second cancer incidence after particle beam therapy for different ion species for individual patients, accounting for differences in relative biological effectiveness (RBE) for the competing processes of tumor initiation and cell inactivation. Our working hypothesis was that use of carbon-ion therapy instead of proton therapy would show a difference in the predicted risk of second cancer incidence in the breast for a sample of Hodgkin lymphoma (HL) patients.

Methods And Materials: We generated biologic treatment plans and calculated relative predicted risks of second cancer in the breast by using two proposed methods: a full model derived from the linear quadratic model and a simpler linear-no-threshold model.

Results: For our reference calculation, we found the predicted risk of breast cancer incidence for carbon-ion plans-to-proton plan ratio, , to be 0.75 ± 0.07 but not significantly smaller than 1 (P=.180).

Conclusions: Our findings suggest that second cancer risks are, on average, comparable between proton therapy and carbon-ion therapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4844193PMC
http://dx.doi.org/10.1016/j.ijrobp.2016.02.032DOI Listing

Publication Analysis

Top Keywords

second cancer
16
carbon-ion therapy
12
proton therapy
12
cancer incidence
12
comparative risk
8
risk predictions
8
predictions second
8
predicted risk
8
therapy
7
second
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!